Status:

TERMINATED

Prescription Methods Assessment Project (PMAP)

Lead Sponsor:

American Academy of Family Physicians

Conditions:

Osteoarthritis

Gastroesophageal Reflux Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to evaluate whether a novel prescription method (N-of-1 intervention)can be successfully integrated into primary care practices and to examine the effects of this prescrip...

Detailed Description

The current prescription writing behavior of physicians is largely an informed decision based upon education and experience. The physician typically assesses the signs and symptoms of a patient presen...

Eligibility Criteria

Inclusion

  • at least 18 years old
  • capable of giving informed consent
  • a new diagnosis or uncontrolled symptoms of either osteoarthritis or gastroesophageal reflux disease
  • if new diagnosis or uncontrolled osteoarthritis, patient must have condition in knee or hip (need not be isolated)

Exclusion

  • too ill to participate
  • not capable of giving informed consent
  • not able to be contacted via phone for study follow-up
  • unable to read English, including blindness
  • if treating physician considers patient to have medical conditions that would cause the patient to be placed at risk by trial participation

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2007

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT00393653

Start Date

October 1 2006

End Date

May 1 2007

Last Update

May 10 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

American Academy of Family Physicians National Research Network

Leawood, Kansas, United States, 66211

Prescription Methods Assessment Project (PMAP) | DecenTrialz